home / stock / vynt / vynt news

VYNT News and Press, Vyant Bio Inc. From 05/17/21

Stock Information
Company Name: Vyant Bio Inc.
Stock Symbol: VYNT
Market: NASDAQ
Website: vyantbio.com
Menu
VYNT VYNT Quote VYNT Short VYNT News VYNT Articles VYNT Message Board
Get VYNT Alerts

News, Short Squeeze, Breakout and More Instantly...
VYNT - IDEX, DISCA, MNMD and ATOS among premarket gainers

Discovery DISCK +24% on definitive agreement with AT&T.Aerpio Pharmaceuticals ARPO +20% on merger deal with Aadi Bioscience.Nuvve Holding Corp. (NVVE) +16%.Aterian (ATER) +13%.Net Element (NETE) +13%.Mind Medicine MNMD +12% on receiving FDA Type C meeting res...
VYNT - Vyant Bio Announces Investor Conference Call and Webcast for First Quarter 2021

CHERRY HILL, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is focused on integrating human-powered scientific and technology-based systems to de-risk and accelerate the discovery and development of preclinical...

VYNT - Vyant Bio to Present at BioNJ's 11th Annual BioPartnering Conference

CHERRY HILL, N.J., May 11, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is a new force in drug discovery, focused on integrating human-powered scientific and technology-based systems to de-risk and accelerate the discovery...

VYNT - ServiceNow, eBay among premarket losers' pack

Adverum Biotechnologies (ADVM) -54% after updates on ADVM-022 diabetic macular edema trial.Cara Therapeutics (CARA) -36% after announces topline results from KARE Phase 2 dose-ranging trial of oral KORSUVA™ in atopic dermatitis patients with moderate-to-severe pruritus.T...
VYNT - Vyant Bio, Inc., Orda?s Bio, and Cellaria, Inc. Announce Collaboration to Design and Qualify Biomarker-Specific Small Protein Therapeutics

New collaboration mitigates risk in drug d iscovery process with artificial intelligence and in vitro “avatar” clinical trials CHERRY HILL, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- Vyant Bio , Inc. (“Vyant” or the “Compa...

VYNT - Vyant Bio Announces Newly Appointed Board of Directors

CHERRY HILL, N.J., April 05, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (the “Company”) (Nasdaq: VYNT), is a new force in drug discovery, focused on integrating human-powered scientific and technology-based systems to de-risk and accelerate the discovery of therapeutics for ...

VYNT - Vyant Bio Announces Investor Webcast to Provide Updates Post Merger between Cancer Genetics and StemoniX

CHERRY HILL, N.J., April 01, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (the “Company”) (Nasdaq: VYNT), is a new force in drug discovery focused on integrating human-powered scientific and technology-based systems to de-risk and accelerate the discovery and development of th...
Previous 10 Next 10